Orphenadrine plasma levels and amelioration of extrapyramidal side effects in schizophrenic patients treated with haloperidol.
D000293:Adolescent; D000328:Adult; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000188:drug therapy; D005260:Female; D006220:Haloperidol / Q000009:adverse effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009966:Orphenadrine / Q000097:blood* / Q000627:therapeutic use; D012559:Schizophrenia / Q000188:drug therapy*
D009966:Orphenadrine; D006220:Haloperidol